BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment

Y Huang, S Qu, G Zhu, F Wang, R Liu… - … the National Cancer …, 2018 - academic.oup.com
… utility of BRAF V600E can be specifically applied to guide precision management. In the …
-stratifying utility of BRAF V600E mutation specifically in assisting the treatment of a unique …

BRAF V600E detection in cytological thyroid samples: a key component of the decision tree for surgical treatment of papillary thyroid carcinoma

JF Collet, R Lacave, S Hugonin, V Poulot… - Head & …, 2016 - Wiley Online Library
… %.1, 2 The optimal surgical treatment of papillary thyroid carcinoma remains controversial. …
, 4 Reoperation per se of patients with papillary thyroid carcinoma has been recently shown to …

[HTML][HTML] … of BRAF V600E mutation and cytomorphological features for the optimization of papillary thyroid cancer diagnostics in cytologically indeterminate thyroid …

A Beiša, M Kvietkauskas, V Beiša… - Experimental and …, 2019 - thieme-connect.com
… biopsies are indeterminate and diagnostic surgery is required. The aim … BRAF V600E
mutation status combined with cytomorphological features for diagnosis of papillary thyroid cancer (…

BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence

S Enumah, A Fingeret, S Parangi… - … journal of surgery, 2020 - Wiley Online Library
… However, the optimal timing and frequency of surveillance to … the BRAF V600E mutation
is associated with an increased risk of recurrence for patients with papillary thyroid carcinoma. …

Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis

C Liu, T Chen, Z Liu - World journal of surgical oncology, 2016 - Springer
… the association between BRAF V600E and the clinical … whether the BRAF V600E mutation
is associated with high-risk … clinical surgeons to choose the optimal surgical managements, …

BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience

F Galuppini, G Pennelli, F Vianello, S Censi… - Clinical Chemistry and …, 2016 - degruyter.com
… Our study confirmed that preoperatively-identified BRAF mutation are associated with certain
pathological features of PTC that correlate with prognosis. We speculate that it has a role in …

Genetic determinants for prediction of outcome of patients with papillary thyroid carcinoma

AA Póvoa, E Teixeira, MR Bella-Cueto, R Batista… - Cancers, 2021 - mdpi.com
… A BRAF V600E point mutation on exon 15 is frequently detected in PTC, accounting for …
The annealing temperature of 61 C was established after protocol optimization for BRAF, NRAS, …

[HTML][HTML] The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer

J Ge, J Wang, H Wang, X Jiang, Q Liao, Q Gong… - … of Cancer, 2020 - ncbi.nlm.nih.gov
BRAF V600E gene mutation is closely related to serum Tg elevation after PTC iodine-131
treatment, suggesting that this mutation … as a predictor of the efficacy of PTC I-131 treatment. …

[HTML][HTML] BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence

A Czarniecka, M Oczko-Wojciechowska… - … surgery, 2016 - ncbi.nlm.nih.gov
… by establishing their own prognostic scales, the aim of which is to group patients into
adequate risk groups, which allows optimization of treatment modality. The following are the most …

[HTML][HTML] Tailored surgery according to molecular analysis in differentiated thyroid carcinomas

P Miccoli, G Materazzi, E Macerola, S Bakkar - Gland Surgery, 2018 - ncbi.nlm.nih.gov
optimal surgical strategy for papillary thyroid carcinoma (PTC) remains a hotly debated topic,
and the concept of offering patients a tailored surgicalBRAF V600E mutation is associated